Neuralstem (AMEX: CUR) awarded DOD Contract for Brain Cancer Research
August 3rd, 2011
No comments
NYSE Amex: CUR received a DOD contract to develop its human neural stem cell technology for the treatment of cancerous brain tumors. Read more…
Categories: AMEX: CUR, DOD Contract for Brain Cancer Research
